Pregnancy, certain digestive disorders, medication interactions, and other medical factors may affect treatment selection
The prospective meta-analysis protocol was registered on PROSPERO under protocol CRD420251012733
For the study, which was published in the journal Molecular and Cellular Neuroscience , researchers reviewed findings from 30 preclinical studiesmostly on animals and cellsthat looked at the impact on signs of Alzheimers disease of four GLP-1 receptor agonists: liraglutide (Victoza, Saxenda), semaglutide (Ozempic, Wegovy), exenatide (Byetta), and dulaglutide (Trulicity)
But specifically for this population, we know that cancer survivors are at greater than a doubling in risk of cardiometabolic disorders and cardiometabolic mortality, and some emerging data that perhaps weight loss may help to lower recurrence risk after a cancer diagnosis
The Myers Cocktail infusion supports energy and nutrient balance
Finally, it is common in current clinical practice for the dose to be adjusted every 4 weeks as needed to maintain goal Hemoglobin